OpenAI's new GPT-4b micro model, developed with Retro Biosciences, aims to re-engineer proteins linked to cellular rejuvenation and longevity, potentially transforming organ and cellular replacement.
The collaboration focuses on Yamanaka factors to convert human skin cells back into a stem cell-like state, potentially extending human lifespan and enhancing regenerative medicine.
Retro Biosciences is optimistic that their partnership with OpenAI will pave the way for advances in biological research and treatment solutions for age-related health issues.
This new model signifies OpenAI's venture into biological sciences, diverging from its primarily AI-centric developments and targeting crucial challenges in healthcare and longevity.
Collection
[
|
...
]